» Articles » PMID: 36359845

Phenotypical and Functional Alteration of γδ T Lymphocytes in COVID-19 Patients: Reversal by Statins

Overview
Journal Cells
Publisher MDPI
Date 2022 Nov 11
PMID 36359845
Authors
Affiliations
Soon will be listed here.
Abstract

(1) Background: statins have been considered an attractive class of drugs in the pharmacological setting of COVID-19 due to their pleiotropic properties and their use correlates with decreased mortality in hospitalized COVID-19 patients. Furthermore, it is well known that statins, which block the mevalonate pathway, affect γδ T lymphocyte activation. As γδ T cells participate in the inflammatory process of COVID-19, we have investigated the therapeutical potential of statins as a tool to inhibit γδ T cell pro-inflammatory activities; (2) Methods: we harvested peripheral blood mononuclear cells (PBMCs) from COVID-19 patients with mild clinical manifestations, COVID-19 recovered patients, and healthy controls. We performed ex vivo flow cytometry analysis to study γδ T cell frequency, phenotype, and exhaustion status. PBMCs were treated with Atorvastatin followed by non-specific and specific stimulation, to evaluate the expression of pro-inflammatory cytokines; (3) Results: COVID-19 patients had a lower frequency of circulating Vδ2+ T lymphocytes but showed a pronounced pro-inflammatory profile, which was inhibited by in vitro treatment with statins; (4) Conclusions: the in vitro capacity of statins to inhibit Vδ2+ T lymphocytes in COVID-19 patients highlights a new potential biological function of these drugs and supports their therapeutical use in these patients.

References
1.
McAuley D, Charles P, Papazian L . Statins in patients with sepsis and ARDS: is it over? We are not sure. Intensive Care Med. 2016; 43(5):677-679. DOI: 10.1007/s00134-016-4454-9. View

2.
Corsale A, Di Simone M, Lo Presti E, Picone C, Dieli F, Meraviglia S . Metabolic Changes in Tumor Microenvironment: How Could They Affect γδ T Cells Functions?. Cells. 2021; 10(11). PMC: 8616133. DOI: 10.3390/cells10112896. View

3.
Oesterle A, Laufs U, Liao J . Pleiotropic Effects of Statins on the Cardiovascular System. Circ Res. 2017; 120(1):229-243. PMC: 5467317. DOI: 10.1161/CIRCRESAHA.116.308537. View

4.
Mehta P, McAuley D, Brown M, Sanchez E, Tattersall R, Manson J . COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020; 395(10229):1033-1034. PMC: 7270045. DOI: 10.1016/S0140-6736(20)30628-0. View

5.
Gorabi A, Kiaie N, Bianconi V, Jamialahmadi T, Al-Rasadi K, Johnston T . Antiviral effects of statins. Prog Lipid Res. 2020; 79:101054. DOI: 10.1016/j.plipres.2020.101054. View